Markets

U.S. open in 40 hrs, 40 mins
10,464.40
30.69
 
0.29%
2,176.05
6.87
 
0.32%
1,110.63
4.98
 
0.45%
100.906
0.3125
 
0.31%
5,364.81
40.85
 
0.77%
9,441.64
40.06
 
0.43%
22,611.80
188.66
 
0.84%
0.0169
 
1.13%
-1.15
 
1.30%
1,189.90
24.10
 
2.07%
77.77
1.75
 
2.30%
Bookmark and Share

Savient Pharma expects $52.9M from stock offer

AP
posted: 47 DAYS 7 HOURS AGO
Text SizeAAA
EAST BRUNSWICK, N.J. -Savient Pharmaceuticals Inc. expects to raise $52.9 million through a stock sale.
The company expanded a stock offering late Thursday, saying it will sell at least 4.3 million shares at $13.29 per share. That matches Thursday's closing price for the stock.
The underwriters of the offer will have the option to buy 645,000 more shares over the next 30 days. Savient announced its offer on Wednesday, saying the proceeds will be used to fund regulatory applications for its chronic gout drug candidate Krystexxa. Savient originally said it would sell up to 4.6 million shares.
The offer is scheduled to close Thursday.
In Friday morning trading, Savient shares rose 98 cents, or 7.4 percent, to $14.27.
Copyright 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
2009-10-09 10:19:20
COMMENTS ( 0 )
GOT SOMETHING TO SAY?
YOU'LL BE ASKED TO REGISTER OR SIGN IN BEFORE POSTING A COMMENT.
Make a Comment
Comment
 
Download the Daily Finance iPhone Application

Headlines From AOL Money & Finance Partners

CNBC
The Big Money
Smart Money
Kiplinger.com
The street

Visit Money & Finance for stock quotes, the web's best online portfolio manager and the latest business & financial news. Find out about every aspect of personal finance and money management, from finding the best mortgage rates and preventing identity theft to making money, saving money and investing money.